Piddock Laura J V, Jin Yu Fang, Webber Mark A, Everett Martin J
Antimicrobial Agents Research Group, Division of Immunity & Infection, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Antimicrob Agents Chemother. 2002 Jul;46(7):2276-8. doi: 10.1128/AAC.46.7.2276-2278.2002.
A ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus (F145) contained no mutations within gyrA, gyrB, grlA, and grlB or within norA or its promoter region. MICs and accumulation studies suggest the role of a novel multidrug efflux pump.
一株对环丙沙星耐药、对萘啶酸敏感的金黄色葡萄球菌突变株(F145)在gyrA、gyrB、grlA和grlB基因内以及norA基因或其启动子区域均未发生突变。最低抑菌浓度(MIC)和蓄积研究提示存在一种新型多药外排泵的作用。